Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Vernalis


Vernalis has raised £25m in a share placing to fund the expansion of its pharmaceuticals research business.
15-Feb-2010


Vernalis is to acquire Cita NeuroPharmaceuticals, the Canadian neurology and central nervous system disorders specialist, for up to £37m.
21-Nov-2005


Vernalis is to acquire Ionix Pharmaceuticals, the Cambridge-based biotechnology company, for £12m.
07-Jul-2005


Vernalis is to merge with British Biotech to create a combined biotechnology group with a market capitalisation of £90m, and the staffing levels will be cut from 204 to 130.
04-Jul-2003


Vernalis is planning to raise £14m in a share offer to fund the expansion of its drug development business, while talks are taking place about a possible bid for the company.
02-May-2003